slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 69,061-69,090
Pages 3,679
Rows per page 30
Component
69,061-69,090 of 110,355
26
The slide uses a checkmark matrix to highlight the competitive advantages of the proposed drug.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
28
Uses a timeline-style visual to list key statistics about the OUD crisis.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
29
The slide uses a line chart to demonstrate reduction in HCQN subscales over time, and a process diagram to outline the ongoing Phase 1/2 trial stages.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
30
The slide uses a feature-comparison matrix to highlight the unique value proposition of DMX-1002 (Ibogaine) against standard MAT and withdrawal support drugs.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
02
Uses a funnel-like visual to connect user growth to market size.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
06
The slide uses a hub-and-spoke style layout to categorize metrics into Customers and Partners, with a background map indicating global reach.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
14
The slide uses a 'from X to Y' framing to demonstrate the breadth of the platform's utility.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
26
Uses a value chain comparison to illustrate market efficiency.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations 1 hit
07
The slide uses a bar chart for revenue, a donut chart for revenue split, and a list for value drivers.Azerion | Results Presentation Deck | 15 slides · Azerion
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
13
The slide uses a three-column layout to categorize operational efficiency initiatives.Azerion | Results Presentation Deck | 15 slides · Azerion
Conference presentation Investor relations Beat · Action1 hit
10
The table presents financial data in £'000s. Footnotes clarify exclusions related to Business Combination.BenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations Beat · Financials1 hit
11
The table details specific non-recurring costs related to a Business Combination, including share-based payments and impairment of assets.BenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations Beat · Financials1 hit
12
The slide provides a bridge between operating loss and cash flow, with explanatory notes on the right side.BenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations Beat · Financials1 hit
13
The slide uses a hub-and-spoke diagram to link the company to its capital allocation priorities.BenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations Beat · Financials1 hit
15
The chart uses a horizontal bar format to show progression through Target ID, Lead Opt, Preclinical, Phase I, and Phase II.BenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations Beat · Traction1 hit
16
The slide uses a treatment flow diagram to show where BEN-2293 fits relative to existing therapies.BenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
18
Includes clinical trial timeline and strategic intent for partnership.BenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
19
The slide contrasts the market size and unmet needs of UC with the specific mechanism and target patient population for BEN-8744.BenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
31
Includes dose-response curves for cytokine inhibition and mouse ear inflammation reduction.BenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations 1 hit
32
The slide uses a flow-chart to represent an adaptive clinical trial design.BenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations 1 hit
33
The chart displays efficacy trends for different dosing regimens of BEN-2293 compared to placebo.BenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations 1 hit
34
Includes a pathway diagram, a volcano plot for differential expression, and a tissue-specific RNAseq expression profile.BenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations 1 hit
35
The slide uses a causal chain framework to link PDE10 inhibition to therapeutic outcomes in IBD.BenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations 1 hit
38
The slide uses a 2x2 matrix to map specific companies like BenevolentAI, Recursion, Exscientia, Schrodinger, and Relay Therapeutics.BenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations 1 hit
07
The slide uses a comparison table to establish product superiority and lists commercial milestones (10k acres, Schnuck Markets agreement).Benson Hill | Investor Presentation Deck | 22 slides · Benson Hill
Conference presentation Investor relations Beat · SolutionLoop · Why Now1 hit
03
The slide uses a Gantt-style visualization to represent clinical trial progress.Bionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · Problem1 hit
05
The chart shows a reduction in alpha 2 band power when BNC210 is administered alongside nicotine compared to nicotine alone.Bionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit
06
The study uses a CCK-4-induced panic attack model to demonstrate Proof of Mechanism (PoM).Bionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit
07
The slide uses three distinct panels to show imaging and behavioral results.Bionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit
09
The chart uses a layered pie/segmentation visual to show the total addressable population vs. the specific opportunity for BNC210.Bionomics | Results Presentation Deck | 27 slides · Bionomics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit